\-\ Texto\\:\\ \ \(0\)\
\-\ mild\\ bilat\\ decreased\\ motor\\ strength\\,\\ otherwise\\ non\\-contributory\\.\ \(0\)\
\-\ inr\\ \\=\\ 1\\.0\ \(0\)\
\-\ wbc\\ \\=\\ 3\\.3\ \(0\)\
\-\ hct\\ \\=41\ \(0\)\
\-\ plt\\ \\=\\ 179\ \(0\)\
\-\ ast\\ \\=\\ 23\ \(0\)\
\-\ alt\\ \\=\\ 35\ \(0\)\
\-\ surgical\\ removal\ \(46\)\
\-\ an\\ extraaxial\\ lesion\\ is\\ seen\\ posteriorly\\ within\\ the\\ spinal\\ canal\\ from\\ the\\ level\\ of\\ t6\\ to\\ t9\\,\\ and\\ exits\\ the\\ neural\\ foramina\\ at\\ the\\ t7\\-t8\\ level\\ bilaterally\\.\\ this\\ lesion\\ presses\\ on\\ the\\ spinal\\ cord\\ and\\ demonstrates\\ isointense\\ t1\\ imaging\\ and\\ hyperintensity\\ on\\ t2\\ imaging\\,\\ with\\ uniform\\ enhancement\\ after\\ gadolinium\\ administration\\.\ \(0\)\
\-\ angiolipoma\\,spine\ \(1\)\
\-\ neurofibroma\ \(78\)\
\-\ schwannoma\ \(67\)\
\-\ atypical\\ meningioma\ \(6\)\
\-\ sarcoid\ \(163\)\
\-\ angiolipoma\ \(2\)\
\-\ a\\ 43\\-year\\-old\\ man\\ with\\ gradual\\ onset\\ of\\ numbness\\ from\\ umbilicus\\ distally\\ into\\ bilateral\\ lower\\ extremities\\,\\ with\\ complaints\\ of\\ inability\\ to\\ run\\ or\\ climb\\ stairs\\ secondary\\ to\\ hip\\ flexure\\ weakness\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ angiolipoma\\:\\ 0\\.33603264568235003\ \(0\)\
\-\ presses\\:\\ 0\\.17375047258578558\ \(0\)\
\-\ climb\\:\\ 0\\.16801632284117501\ \(0\)\
\-\ spinal\\:\\ 0\\.1614701543953577\ \(0\)\
\-\ 179\\:\\ 0\\.15420034294881832\ \(0\)\
\-\ exits\\:\\ 0\\.15185266254568264\ \(0\)\
\-\ bilat\\:\\ 0\\.1497525908630698\ \(0\)\
\-\ umbilicus\\:\\ 0\\.14304594357967523\ \(0\)\
\-\ t6\\:\\ 0\\.1403843630564616\ \(0\)\
\-\ t9\\:\\ 0\\.13917597820041852\ \(0\)\
\-\ run\\:\\ 0\\.13917597820041852\ \(0\)\
\-\ level\\:\\ 0\\.1373637026122323\ \(0\)\
\-\ gradual\\:\\ 0\\.12853051487975484\ \(0\)\
\-\ stairs\\:\\ 0\\.12595503490370957\ \(0\)\
\-\ flexure\\:\\ 0\\.12422070276096919\ \(0\)\
\-\ extraaxial\\:\\ 0\\.12367457967618885\ \(0\)\
\-\ foramina\\:\\ 0\\.12262527184707003\ \(0\)\
\-\ plt\\:\\ 0\\.12212063107835634\ \(0\)\
\-\ inr\\:\\ 0\\.12162845185782957\ \(0\)\
\-\ imaging\\:\\ 0\\.1195072174003959\ \(0\)\
\-\ distally\\:\\ 0\\.11933486170681822\ \(0\)\
\-\ uniform\\:\\ 0\\.1189061947408014\ \(0\)\
\-\ inability\\:\\ 0\\.11727816816031557\ \(0\)\
\-\ the\\:\\ 0\\.11343712933616114\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.11338522612643881\ \(0\)\
\-\ neurofibroma\\:\\ 0\\.112443370016711\ \(0\)\
\-\ alt\\:\\ 0\\.10932704173124956\ \(0\)\
\-\ ast\\:\\ 0\\.10906648578995597\ \(0\)\
\-\ lesion\\:\\ 0\\.10902136822339181\ \(0\)\
\-\ hct\\:\\ 0\\.10781247196547285\ \(0\)\
\-\ sarcoid\\:\\ 0\\.10663270483965191\ \(0\)\
\-\ neural\\:\\ 0\\.10530339597869261\ \(0\)\
\-\ isointense\\:\\ 0\\.10288440156146705\ \(0\)\
\-\ numbness\\:\\ 0\\.10107112972871297\ \(0\)\
\-\ posteriorly\\:\\ 0\\.10022282103825342\ \(0\)\
\-\ schwannoma\\:\\ 0\\.09743705166671528\ \(0\)\
\-\ strength\\:\\ 0\\.09525050589759923\ \(0\)\
\-\ gadolinium\\:\\ 0\\.09473939467089147\ \(0\)\
\-\ 23\\:\\ 0\\.09375488613706139\ \(0\)\
\-\ complaints\\:\\ 0\\.09363517258995893\ \(0\)\
\-\ atypical\\:\\ 0\\.09328028643759982\ \(0\)\
\-\ 35\\:\\ 0\\.09116849335172315\ \(0\)\
\-\ administration\\:\\ 0\\.09054555997660807\ \(0\)\
\-\ motor\\:\\ 0\\.09044360453346194\ \(0\)\
\-\ from\\:\\ 0\\.09031426018887476\ \(0\)\
\-\ canal\\:\\ 0\\.08751684609892225\ \(0\)\
\-\ hip\\:\\ 0\\.08734200071745443\ \(0\)\
\-\ removal\\:\\ 0\\.08691148191461039\ \(0\)\
\-\ extremities\\:\\ 0\\.0864068411458967\ \(0\)\
\-\ to\\:\\ 0\\.0852749162769821\ \(0\)\
\-\ meningioma\\:\\ 0\\.0851984562898536\ \(0\)\
\-\ cord\\:\\ 0\\.08428186971529157\ \(0\)\
\-\ weakness\\:\\ 0\\.08298147960539812\ \(0\)\
\-\ otherwise\\:\\ 0\\.08104996914447686\ \(0\)\
\-\ wbc\\:\\ 0\\.08036365814624903\ \(0\)\
\-\ bilaterally\\:\\ 0\\.07583022848324539\ \(0\)\
\-\ spine\\:\\ 0\\.07511057466059555\ \(0\)\
\-\ onset\\:\\ 0\\.07301050297798273\ \(0\)\
\-\ t1\\:\\ 0\\.07084269207749433\ \(0\)\
\-\ and\\:\\ 0\\.07048462353863016\ \(0\)\
\-\ decreased\\:\\ 0\\.07042859842632158\ \(0\)\
\-\ on\\:\\ 0\\.06867917545590492\ \(0\)\
\-\ secondary\\:\\ 0\\.06739332060153795\ \(0\)\
\-\ with\\:\\ 0\\.0667921036034056\ \(0\)\
\-\ of\\:\\ 0\\.06675221916835868\ \(0\)\
\-\ enhancement\\:\\ 0\\.0654441906773515\ \(0\)\
\-\ t2\\:\\ 0\\.06541519831489338\ \(0\)\
\-\ mild\\:\\ 0\\.06445374051368079\ \(0\)\
\-\ bilateral\\:\\ 0\\.0611069957770571\ \(0\)\
\-\ into\\:\\ 0\\.060441378229115925\ \(0\)\
\-\ man\\:\\ 0\\.060194605575188936\ \(0\)\
\-\ lower\\:\\ 0\\.05810122368813336\ \(0\)\
\-\ demonstrates\\:\\ 0\\.05712203635379205\ \(0\)\
\-\ surgical\\:\\ 0\\.05526228884699246\ \(0\)\
\-\ after\\:\\ 0\\.055158113109805104\ \(0\)\
\-\ seen\\:\\ 0\\.05352940742994692\ \(0\)\
\-\ within\\:\\ 0\\.052367073943522836\ \(0\)\
\-\ an\\:\\ 0\\.043478797274011965\ \(0\)\
\-\ at\\:\\ 0\\.042946224677073916\ \(0\)\
\-\ or\\:\\ 0\\.03955447736769434\ \(0\)\
\-\ this\\:\\ 0\\.03906963618904195\ \(0\)\
\-\ is\\:\\ 0\\.03113773156324537\ \(0\)\
